Non-Responders and Dropouts in CGRP Inhibitor Treatment

Discussion on the challenges of non-responders and dropouts in long-term CGRP inhibitor treatment for migraines, the difficulty in finding a single biomarker to predict treatment response, and the need for robust markers in clinical practice.